![](/img/cover-not-exists.png)
PCN75 COST-EFFECTIVENESS ANALYSIS OF EGFR MUTATION TESTING IN PATIENTS WITH ADVANCED NON SMALL-CELL LUNG CANCER (ANSCLC) TREATED WITH GEFITINIB OR CARBOPLATIN-PACLITAXEL
O Arrieta, P Anaya, RJ López, AC PolancoVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72164-1
File:
PDF, 95 KB
english, 2010